Free Trial
→ New Rule Hits in July — The Smart Money Already Moved (From American Alternative) (Ad) Buy ACHL Stock  Free ACHL Stock Alerts

Achilles Therapeutics (ACHL) Short Interest Ratio & Short Volume

Achilles Therapeutics logo
$1.48 0.00 (0.00%)
As of 03/26/2025
Compare

Achilles Therapeutics Short Interest Data

Achilles Therapeutics (ACHL) has a short interest of 478,300 shares, representing 1.26% of the float (the number of shares available for trading by the public). This marks a -40.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 668,052 shares to cover all short positions.

Current Short Interest
478,300 shares
Previous Short Interest
797,900 shares
Change Vs. Previous Month
-40.06%
Dollar Volume Sold Short
$660.05 thousand
Short Interest Ratio
0.4 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
41,100,000 shares
Float Size
37,950,000 shares
Short Percent of Float
1.26%
Today's Trading Volume
0 shares
Average Trading Volume
668,052 shares
Today's Volume Vs. Average
0%
Short Selling Achilles Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Achilles Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ACHL Short Interest Over Time

ACHL Days to Cover Over Time

ACHL Percentage of Float Shorted Over Time

Achilles Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/2025478,300 shares $660.05 thousand -40.1%1.3%0.4 $1.38
2/15/2025797,900 shares $1.10 million +1,280.5%2.1%1 $1.38
1/31/202557,800 shares $65.31 thousand -52.8%0.2%0.1 $1.13
1/15/2025122,400 shares $141.98 thousand +0.1%0.3%0.7 $1.16
12/31/2024122,300 shares $139.42 thousand +35.4%0.3%0.7 $1.14
12/15/202490,300 shares $89.39 thousand -33.9%0.2%0.6 $0.99
11/30/2024136,700 shares $146.95 thousand -36.6%0.4%0.2 $1.08
11/15/2024215,700 shares $226.49 thousand +35.4%0.6%0.3 $1.05
10/31/2024159,300 shares $160.10 thousand -25.1%0.4%0.2 $1.01
10/15/2024212,600 shares $208.22 thousand -40.6%0.6%0.3 $0.98
9/30/2024358,100 shares $365.26 thousand +9,082.1%0.9%0.6 $1.02
9/15/20243,900 shares $2.82 thousand No Change0.0%0 $0.72
8/31/20243,900 shares $2.81 thousand -53.6%0.0%0.1 $0.72
8/15/20248,400 shares $6.22 thousand -56.3%0.0%0.2 $0.74
7/31/202419,200 shares $15.37 thousand +92.0%0.1%0.3 $0.80
7/15/202410,000 shares $8.39 thousand -9.9%0.0%0.1 $0.84
6/30/202411,100 shares $9.05 thousand -52.8%0.0%0.1 $0.82
6/15/202423,500 shares $21.20 thousand -15.5%0.1%0.1 $0.90
5/31/202427,800 shares $25.58 thousand +101.5%0.1%0.1 $0.92
5/15/202413,800 shares $12.70 thousand -42.5%0.0%0 $0.92
4/30/202424,000 shares $18 thousand -36.5%0.1%0 $0.75
4/15/202437,800 shares $31.37 thousand -49.5%0.1%0 $0.83
3/31/202474,800 shares $93.50 thousand +8.6%0.2%0.1 $1.25
3/15/202468,900 shares $75.79 thousand -55.2%0.2%0.1 $1.10
2/29/2024153,700 shares $202.88 thousand +340.4%0.4%0.2 $1.32
2/15/202434,900 shares $33.50 thousand +245.5%0.1%0.1 $0.96
1/31/202410,100 shares $9.39 thousand -79.5%0.0%0 $0.93
1/15/202449,200 shares $43.59 thousand +131.0%0.1%0.3 $0.89
12/31/202321,300 shares $18.94 thousand -29.2%0.1%0.2 $0.89
12/15/202330,100 shares $26.19 thousand +16.2%0.1%0.3 $0.87
11/30/202325,900 shares $21.40 thousand -44.7%0.1%0.4 $0.83
11/15/202346,800 shares $37.49 thousand +22.2%0.1%0.9 $0.80
10/31/202338,300 shares $32.94 thousand +3.5%0.1%0.7 $0.86
10/15/202337,000 shares $33.45 thousand -21.9%0.1%0.6 $0.90
9/30/202347,400 shares $43.13 thousand +4.4%0.1%0.6 $0.91
9/15/202345,400 shares $40.36 thousand +20.4%0.1%0.5 $0.89
8/31/202337,700 shares $34.33 thousand -11.1%0.1%0.4 $0.91
8/15/202342,400 shares $41.13 thousand -27.8%0.1%0.4 $0.97
7/31/202358,700 shares $59.87 thousand +36.5%0.2%0.6 $1.02
7/15/202343,000 shares $42.57 thousand +50.9%0.1%0.3 $0.99
New Rule Hits in July — The Smart Money Already Moved (Ad)

A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.

To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how
6/30/202328,500 shares $26.94 thousand -0.4%0.1%0.2 $0.95
6/15/202328,600 shares $28.03 thousand +50.5%0.1%0.2 $0.98
5/31/202319,000 shares $19 thousand +28.4%0.1%0.1 $1.00
5/15/202314,800 shares $14.36 thousand +114.5%0.0%0.1 $0.97
4/30/20236,900 shares $5.73 thousand -57.9%0.0%0 $0.83
4/15/202316,400 shares $14.60 thousand +26.2%0.0%0.1 $0.89
3/31/202313,000 shares $12.45 thousand +106.4%0.0%0.1 $0.96
3/15/20236,300 shares $5.83 thousand -33.7%0.0%0 $0.93
2/28/20239,500 shares $10.45 thousand -78.0%0.0%0 $1.10
2/15/202343,200 shares $48.38 thousand +163.4%0.1%0.1 $1.12
1/31/202316,400 shares $20.34 thousand -49.2%0.0%0 $1.24
1/15/202332,300 shares $38.11 thousand -59.1%0.1%0.1 $1.18
12/30/202279,000 shares $71.10 thousand -30.9%0.2%0.2 $0.90
12/15/2022114,300 shares $125.73 thousand -9.3%0.3%0.7 $1.10
11/30/2022126,000 shares $254.52 thousand +2.1%0.3%2.4 $2.02
11/15/2022123,400 shares $213.48 thousand +72.4%0.3%2.5 $1.73
10/31/202271,600 shares $138.19 thousand +37.4%0.2%2.7 $1.93
10/15/202252,100 shares $109.41 thousand -1.1%0.1%1.9 $2.10
9/30/202252,700 shares $119.10 thousand +6.3%0.1%1.6 $2.26
9/15/202249,600 shares $144.83 thousand +4.2%0.1%1.4 $2.92
8/31/202247,600 shares $138.52 thousand -5.0%0.1%1.2 $2.91
8/15/202250,100 shares $162.83 thousand -5.8%0.1%1.2 $3.25
7/31/202253,200 shares $135.66 thousand +0.6%0.1%1.1 $2.55
7/15/202252,900 shares $140.19 thousand +0.8%0.1%0.9 $2.65
6/30/202252,500 shares $132.30 thousand -18.7%0.1%0.5 $2.52
6/15/202264,600 shares $148.58 thousand +7.1%0.2%0.6 $2.30
5/31/202260,300 shares $150.75 thousand -30.0%0.2%0.5 $2.50
5/15/202286,100 shares $191.14 thousand +41.9%0.2%0.8 $2.22
4/30/202260,700 shares $134.75 thousand -59.8%0.2%0.6 $2.22
4/15/2022150,800 shares $357.40 thousand +20.1%0.4%1.5 $2.37
3/31/2022125,600 shares $369.26 thousand +114.0%0.3%1.6 $2.94
3/15/202258,700 shares $174.93 thousand -2.3%0.2%1.1 $2.98
2/28/202260,100 shares $198.93 thousand -19.5%0.2%0.9 $3.31
2/15/202274,700 shares $258.46 thousand +3.8%0.2%1 $3.46
1/31/202272,000 shares $273.60 thousand +6.2%0.2%0.6 $3.80
1/15/202267,800 shares $275.95 thousand -12.4%0.2%0.5 $4.07
12/31/202177,400 shares $387.77 thousand +4.5%0.2%0.4 $5.01
12/15/202174,100 shares $330.49 thousand +9.9%0.2%0.3 $4.46
11/30/202167,400 shares $343.74 thousand -95.3%0.2%0.3 $5.10
11/15/20211,430,000 shares $8.15 million +33.6%3.7%5.8 $5.70
10/29/20211,070,000 shares $6.57 million +21.3%2.7%3.7 $6.14
10/15/2021882,000 shares $6.71 million +15.2%2.3%3.4 $7.61
9/30/2021765,900 shares $5.97 million +29.0%2.0%3.4 $7.79
9/15/2021593,700 shares $3.45 million +1.3%1.5%4.5 $5.81
8/31/2021586,300 shares $3.98 million -0.9%1.5%4.7 $6.78
8/13/2021591,800 shares $3.82 million No Change1.5%5.2 $6.45

ACHL Short Interest - Frequently Asked Questions

What is Achilles Therapeutics' current short interest?

Short interest is the volume of Achilles Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 478,300 shares of ACHL short. 1.26% of Achilles Therapeutics' shares are currently sold short. Learn More on Achilles Therapeutics' current short interest.

What is a good short interest percentage for Achilles Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.26% of Achilles Therapeutics' floating shares are currently sold short.

Is Achilles Therapeutics' short interest increasing or decreasing?

Achilles Therapeutics saw a decline in short interest in February. As of February 28th, there was short interest totaling 478,300 shares, a decline of 40.1% from the previous total of 797,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Achilles Therapeutics' float size?

Achilles Therapeutics currently has issued a total of 41,100,000 shares. Some of Achilles Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Achilles Therapeutics currently has a public float of 37,950,000 shares.

How does Achilles Therapeutics' short interest compare to its competitors?

1.26% of Achilles Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Achilles Therapeutics: Nanobiotix S.A. (0.01%), Tevogen Bio Holdings Inc. (6.70%), Esperion Therapeutics, Inc. (13.54%), Acelyrin, Inc. (4.87%), Sagimet Biosciences Inc. (15.50%), Instil Bio, Inc. (18.31%), Y-mAbs Therapeutics, Inc. (7.91%), CytomX Therapeutics, Inc. (26.05%), MediWound Ltd. (12.82%), Design Therapeutics, Inc. (11.86%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Corporation ($4.45 billion), Capital One Financial Corporation ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short Achilles Therapeutics stock?

Short selling ACHL is an investing strategy that aims to generate trading profit from Achilles Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Achilles Therapeutics?

A short squeeze for Achilles Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHL, which in turn drives the price of the stock up even further.

How often is Achilles Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHL, twice per month. The most recent reporting period available is February, 28 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:ACHL) was last updated on 6/25/2025 by MarketBeat.com Staff
From Our Partners
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Trump’s true trade war strategy
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored